ProShare Advisors’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,935
| Closed | -$663K | – | 1885 |
|
|
2023
Q2 | $663K | Buy |
15,935
+81
| +0.5% | +$3.33K | ﹤0.01% | 835 |
|
|
2023
Q1 | $655K | Buy |
15,854
+6,804
| +75% | +$291K | ﹤0.01% | 819 |
|
|
2022
Q4 | $373K | Sell |
9,050
-396
| -4% | -$16K | ﹤0.01% | 1109 |
|
|
2022
Q3 | $414K | Sell |
9,446
-149
| -2% | -$7.22K | ﹤0.01% | 979 |
|
|
2022
Q2 | $472K | Sell |
9,595
-5,270
| -35% | -$283K | ﹤0.01% | 965 |
|
|
2022
Q1 | $843K | Sell |
14,865
-2,415
| -14% | -$128K | ﹤0.01% | 986 |
|
|
2021
Q4 | $907K | Buy |
17,280
+5,854
| +51% | +$318K | ﹤0.01% | 1077 |
|
|
2021
Q3 | $684K | Sell |
11,426
-7,783
| -41% | -$480K | ﹤0.01% | 1045 |
|
|
2021
Q2 | $1.3M | Buy |
19,209
+557
| +3% | +$38K | ﹤0.01% | 890 |
|
|
2021
Q1 | $1.22M | Buy |
18,652
+2,327
| +14% | +$140K | ﹤0.01% | 888 |
|
|
2020
Q4 | $920K | Buy |
16,325
+5,680
| +53% | +$279K | ﹤0.01% | 920 |
|
|
2020
Q3 | $517K | Sell |
10,645
-558
| -5% | -$30.1K | ﹤0.01% | 931 |
|
|
2020
Q2 | $624K | Buy |
11,203
+5,315
| +90% | +$307K | ﹤0.01% | 860 |
|
|
2020
Q1 | $298K | Sell |
5,888
-6,808
| -54% | -$456K | ﹤0.01% | 872 |
|
|
2019
Q4 | $982K | Buy |
12,696
+1,641
| +15% | +$116K | ﹤0.01% | 801 |
|
|
2019
Q3 | $701K | Buy |
11,055
+221
| +2% | +$13.8K | ﹤0.01% | 868 |
|
|
2019
Q2 | $634K | Sell |
10,834
-1,104
| -9% | -$65.2K | ﹤0.01% | 919 |
|
|
2019
Q1 | $678K | Buy |
11,938
+1,601
| +15% | +$85.1K | ﹤0.01% | 919 |
|
|
2018
Q4 | $512K | Sell |
10,337
-2,016
| -16% | -$121K | ﹤0.01% | 940 |
|
|
2018
Q3 | $877K | Sell |
12,353
-7
| -0.1% | -$445 | 0.01% | 878 |
|
|
2018
Q2 | $644K | Buy |
12,360
+231
| +2% | +$12.1K | ﹤0.01% | 1009 |
|
|
2018
Q1 | $633K | Sell |
12,129
-1,183
| -9% | -$60K | ﹤0.01% | 1007 |
|
|
2017
Q4 | $779K | Buy |
13,312
+5,376
| +68% | +$305K | 0.01% | 934 |
|
|
2017
Q3 | $440K | Sell |
7,936
-1,107
| -12% | -$73.3K | ﹤0.01% | 1011 |
|
|
2017
Q2 | $696K | Sell |
9,043
-1,926
| -18% | -$144K | 0.01% | 842 |
|
|
2017
Q1 | $819K | Sell |
10,969
-2,552
| -19% | -$185K | 0.01% | 817 |
|
|
2016
Q4 | $911K | Buy |
13,521
+3,981
| +42% | +$257K | 0.01% | 819 |
|
|
2016
Q3 | $636K | Buy |
9,540
+712
| +8% | +$45.4K | 0.01% | 848 |
|
|
2016
Q2 | $527K | Buy |
8,828
+692
| +9% | +$37.4K | 0.01% | 948 |
|
|
2016
Q1 | $396K | Sell |
8,136
-1,958
| -19% | -$88.9K | 0.01% | 1093 |
|
|
2015
Q4 | $546K | Buy |
10,094
+2,778
| +38% | +$142K | 0.01% | 999 |
|
|
2015
Q3 | $353K | Buy |
7,316
+338
| +5% | +$17.5K | 0.01% | 1074 |
|
|
2015
Q2 | $331K | Sell |
6,978
-3,318
| -32% | -$155K | ﹤0.01% | 1269 |
|
|
2015
Q1 | $474K | Sell |
10,296
-889
| -8% | -$41.3K | 0.01% | 1204 |
|
|
2014
Q4 | $527K | Sell |
11,185
-8,494
| -43% | -$354K | 0.01% | 1170 |
|
|
2014
Q3 | $686K | Sell |
19,679
-4,848
| -20% | -$173K | 0.01% | 1221 |
|
|
2014
Q2 | $872K | Sell |
24,527
-21,203
| -46% | -$726K | 0.01% | 1229 |
|
|
2014
Q1 | $1.76M | Buy |
+45,730
| New | +$1.68M | 0.02% | 844 |
|
|
2013
Q4 | – | Sell |
-29,022
| Closed | -$711K | – | 1963 |
|
|
2013
Q3 | $711K | Sell |
29,022
-636
| -2% | -$15.7K | 0.02% | 1151 |
|
|
2013
Q2 | $735K | Buy |
+29,658
| New | +$649K | 0.01% | 1042 |
|
Other funds holding NUVA
ProShare Advisors's NUVA Position: Q3 2023 in Review
ProShare Advisors sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 15,935 shares — an estimated $663K sold.
ProShare Advisors first reported a position in NUVA in Q2 2013 and held it in 40 quarters. The position peaked at $1.76M in Q1 2014. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- ProShare Advisors reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- ProShare Advisors sold 15,935 NuVasive, Inc. shares in Q3 2023, an estimated $663K.
- ProShare Advisors first reported a position in NuVasive, Inc. in Q2 2013 and held it in 40 quarters.
- ProShare Advisors's NuVasive, Inc. position peaked at $1.76M in Q1 2014.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on ProShare Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.